维普中文期刊产品整合服务
9篇 您的检索式:作者名="Ceola"
    题名 作者 年代 出处 被引量
1Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster 显示文摘Zambon M Ceola M Almeida-De-Castro R 2008J Crit Care2008,23,4:1
2Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock:we could go faster显示文摘Zambon M Ceola M Almeida-de-Castro R 0,,4:1
3MINT,the molecular interaction database:2009 update显示文摘CeolA Chatr Aryamontri A Licata L 0,,1:1
4Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster 显示文摘Zambon M Ceola M Almeida-de-Castro R 2008J Crit Care2008,23,4:1
5查看详情显示文摘Valentin M D Ceola S Agostini G Giacometti G M Angerhofer A Crescenzi O Barone V Carbonera D 0,,:1
6Implementation of the Surviving Sepsis Campaign guide- lines for severe sepsis and septic shock: we could go fas- ter 显示文摘Zambon M Ceola M Almeida- de -Castro R 2008J Crit Care2008,23,4:1
7Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock:We could go faster显示文摘Zambon M Ceola M Almeida-de-Castro R 2008Journal of Critical Care2008,23,4:1
8Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock:We could go faster 显示文摘Zambon M Ceola M Almeida-de-Castro R 2008J Crit Care2008,23,4:1
9Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis:A comprehensive review显示文摘Mastocytosis is a rare and heterogeneous disease characterized by various clinical and biological features that affect different prognoses and treatments.The disease is usually divided into 2 principal categories:cutaneous and systemic disease(SM).Clinical features can be related to mast cell(MC)mediator release or pathological MC infiltration.SM is a disease often hard to identify,and the diagnosis is based on clinical,biological,histological,and molecular criteria with different specialists involved in the patient’s clinical work-up.Among all manifestations of the disease,gastrointestinal(GI)symptoms are common,being present in 14%-85% of patients,and can significantly impair the quality of life.Here we review the data regarding GI involvement in SM,in terms of clinical presentations,histological and endoscopic features,the pathogenesis of GI symptoms,and their treatment.Alessandra Elvevi Elena Maria Elli Martina Luca Miki Scaravaglio Fabio Pagni Stefano Ceola Laura Ratti Pietro Invernizzi Sara Massironi 2022World Journal of Gastroenterology2022,28,29:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费